Medindia LOGIN REGISTER
Medindia

FDA Issues Warning on Rare Muscle Injury

by Rajashri on Aug 12 2008 5:10 PM

The U.S. Food and Drug Administration has warned that patients using a combination of simvastatin and anti-arrhythmia medicine amiodarone could suffer a rare fatal muscle injury.

The injury called rhabdomyolysis may lead to kidney failure or even death.

The FDA said it had already warned about this condition in 2002, but that patients were still being prescribed this combination.

Source-Medindia
RAS/L


Advertisement